An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Anxiety Disorders

Interventions

DRUG

SR58611A

Trial Locations (5)

Sanofi-Aventis Administrative Office, Vienna

Sanofi-Aventis Administrative Office, Zagreb

Sanofi-Aventis Administrative Office, Helsinki

Sanofi-Aventis Administrative Office, Bucharest

Sanofi-Aventis Administrative Office, Bratislava